Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03688139 · ClinicalTrials.gov registry record · NA
Reward Function and Therapy for Late-Life Depression
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03688139 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 65 participants.
The verdict
NCT03688139, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The goal of this study is to learn about changes in the brain that occur during Engage, a psychotherapy for depression in older adults, and how they may differ from changes that occur during supportive therapy. Older adults with depression will receive 9 weeks of either Engage or supportive therapy and will complete research assessments before the therapy begins and at weeks 3, 6, and 9 of treatment. Research assessments will include questionnaires, computer tasks, and recordings of electrical brain activity (also called electroencephalography or EEG).
Interventions
- BEHAVIORAL Supportive Therapy
- BEHAVIORAL Engage Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2024-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03688139
The ClinicalTrials.gov registry entry for NCT03688139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.
NCT03688139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03688139 about?
NCT03688139 is a clinical study titled "Reward Function and Therapy for Late-Life Depression". The goal of this study is to learn about changes in the brain that occur during Engage, a psychotherapy for depression in older adults, and how they may differ from changes that occur during supportive therapy. Older adults with depression will receive 9 weeks of either Engage or supportive therapy ...
What is the current status of trial NCT03688139?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-03-14. Estimated completion is 2024-01-18.
What interventions are being tested in trial NCT03688139?
The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Engage Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03688139?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.